Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Samelisant (SUVN-G3031) in Narcolepsy
NCT04072380Phase 2Completed
- Sponsor
- Suven Life Sciences
- Start
- Sep 2019
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Samelisant in narcolepsy, sponsored by Suven Life Sciences. Started Sep 2019; status: completed.
02
Drugs
Samelisant
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT04072380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04072380.